Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat rare and ultra rare diseases.
12 employees · est. 2013 · Watertown, United States
Eloxx Pharmaceuticals is the older company (2013 vs 2017); Jnana Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Eloxx Pharmaceuticals | Jnana Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2017 |
| Headquarters | ||
| Headquarters | Watertown, United States | Boston, United States |
| Employees | ||
| Employees | 12 | 92 larger |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Series C |
| Total Funding | ||
| Total Funding | $63.29M | $207.00M |
| Funding Rounds | ||
| Funding Rounds | 11 | 3 |
| Services | ||
| Services | Development of small molecule genetic therapies, Research in ribosomal mutation correction, Treatment pipeline for rare genetic diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Patients with rare genetic disorders, Research institutions, Biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharma, RNA-modulating Drug Candidates, Premature Stop Codon Diseases, Rare Diseases, Ultra-rare Diseases, Genetic Diseases, MRNA Half-life, Protein Synthesis, ELX-02, Cystic Fibrosis, Cystinosis, Clinical-stage Biopharmaceutical Company, Drug Development, Regulatory Approval, Waltham, MA | Drug Discovery, Clinical-stage, Rare Diseases, Immune-mediated Diseases, Small Molecule Drugs, Metabolic Diseases, Phenylketonuria, Chemoproteomics, Allosteric Site Targeting, SLC6A19, Boston-based, Investment-backed, Scientific Leadership, Bain Capital Life Sciences |
| Website | ||
| Website | eloxxpharma.com | jnanatx.com |
About Eloxx Pharmaceuticals
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company on the cutting edge of developing RNA-modulating drug candidates aimed at treating rare and ultra-rare diseases. Their motto, "Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat rare and ultra...
About Jnana Therapeutics
Jnana Therapeutics is a clinical-stage biotechnology company utilizing its next-generation chemoproteomics RAPID platform to discover medications for highly validated, challenging-to-drug targets, addressing diseases with high unmet need. The company's focus lies in developing first- and best-in-cla...
We will tell you when either one moves
BounceWatch watches Eloxx Pharmaceuticals and Jnana Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Eloxx Pharmaceuticals and Jnana Therapeutics — by email.
Frequently Asked Questions
Compare Eloxx Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Eloxx Pharmaceuticals on 12 Sep 2024, and Jnana Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
